How does Abcam use and develop cell-based assays to test protein bioactivity?
Abcam scientist, Dr. Jimmy Theriault, discusses how to determine if proteins are functionally active using cell-based and biochemical assays
Abcam scientist, Dr. Jimmy Theriault, discusses how to determine if proteins are functionally active using cell-based and biochemical assays
Dr. Bruce Budowle discusses how probabilistic genotyping is helping forensic labs identify low-level, degraded DNA samples
Abcam scientist Dr. Yongwon Kwon discusses a new method that could help scientists simplify their gene-editing processes and extend the validation of cancer cells
R&D expert Dr. Francisco Ylera shares the secret to fast and flexible formatting of antibodies to accelerate your research
Explore best practices and understand the benefits of making the switch to spectral flow cytometry
Survey finds fear and misconceptions around hepatitis discourage testing, with more than half of respondents assuming they are not at risk
Discover how Invisible-Light Labs is redefining nanoscale analysis with EMILIE, boosting sensitivity and cutting sampling times for breakthroughs in environmental monitoring, nanotechnology, and beyond
Discover how sustainability, efficiency, automation and other trends are impacting diagnostic innovation and improving healthcare outcomes
Activities highlight comprehensive diagnostics solutions to help effectively assess clinical risk and diagnose disease, advance precision medicine and further clinical research
Full screening service to validate the 3´UTR targets of specific miRNAs
Explore the concerted effort healthcare professionals, pharma, and biotech are making to combat cervical cancer through the development and implementation of new HPV assays
Forensics Europe Expo will be taking place on 5-6 March 2019, Olympia, London
The automated volume reduction instrument from Menarini Silicon Biosystems was debuted at 25th annual meeting of the Association for Molecular Pathology
Swift Biosciences and SeraCare Partner on Circulating Tumor DNA Standards for NGS-Based Oncology Assays